Hap Trading, LLC Astrazeneca PLC Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $649,237 - $740,085	10,638 New	10,638 $721 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $8.87 Million - $10.1 Million	-140,405 Reduced 85.65%	23,520 $1.63 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $3.48 Million - $4.53 Million	64,262 Added 64.48%	163,925 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $1.88 Million - $4.82 Million	-35,513 Reduced 26.27%	99,663 $5.47 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $6.04 Million - $7.25 Million	101,849 Added 305.61%	135,176 $8.93 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $6.34 Million - $7.64 Million	-113,758 Reduced 77.34%	33,327 $2.21 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $830,179 - $980,939	15,368 Added 11.67%	147,085 $8.57 Million
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $202,016 - $221,032	-3,636 Reduced 2.69%	131,717 $7.91 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $5 Million - $6.22 Million	103,298 Added 322.25%	135,353 $8.11 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $19,901 - $22,973	-422 Reduced 1.3%	32,055 $1.59 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $42,746 - $51,115	881 Added 2.79%	32,477 $1.62 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $97,701 - $112,485	-1,841 Reduced 5.51%	31,596 $1.73 Million
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $399,106 - $512,170	9,260 Added 38.3%	33,437 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $234,491 - $262,167	6,290 Added 35.17%	24,177 $998,000
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $1.11 Million - $1.35 Million	-31,362 Reduced 63.68%	17,887 $723,000
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $1.01 Million - $1.12 Million	30,624 Added 164.42%	49,249 $1.72 Million
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $597,676 - $647,777	18,625	18,625 $646,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account